Supernus Pharmaceuticals, Inc. - Common Stock (NQ:SUPN)
Price and Volume
Detailed Quote| Volume | 2,818,867 |
| Open | 42.07 |
| Bid (Size) | 41.92 (5,000) |
| Ask (Size) | 59.50 (100) |
| Prev. Close | 41.84 |
| Today's Range | 39.53 - 43.72 |
| 52wk Range | 37.54 - 59.68 |
| Shares Outstanding | 53,145,884 |
| Dividend Yield | N/A |
Top News
More News
Performance
52-Week Range
29.8% below 52-week high
41.92
37.5452W Low
59.6852W High
1 Week
5.4% below 1-week high
39.581W Low
44.311W High
Supernus Pharmaceuticals, Inc. - Common Stock (SUPN) traded between $37.54 and $59.68 over the past 52 weeks and last traded at $41.92, 29.8% below its 52-week high. Over the past week it ranged between $39.58 and $44.31.
Past 12 Months
1W
+$1.22
1M
-$2.05
3M
-$3.69
6M
-$6.08
YTD
-$7.55
1Y
-$13.76
SUPN was -24.7% over the past year, -12.7% over six months, -15.3% year to date, +3.0% in the last week.
12 Months vs Market
SUPN
-24.7%
DIA
+8.6%
SPY
+9.9%
QQQ
+8.6%
IWM
+13.2%
Over the past 12 months SUPN returned -24.7% versus DIA (Dow) +8.6%, SPY (S&P 500) +9.9%, QQQ (Nasdaq 100) +8.6% and IWM (Russell 2000) +13.2%.
Volume & Liquidity
3.20× 3-mo avg
Today 2,818,867
3-mo avg 880.1K
1W
1.2M
1M
984.9K
3M
880.1K
6M
827.4K
YTD
771.8K
1Y
790.2K
SUPN most recently traded 2,818,867 shares against a 3-month average daily volume of 880.1K.
More News
Read More
Supernus Pharmaceuticals Q3 Earnings Call Highlights ↗
October 29, 2026
Supernus Announces Third Quarter 2026 Financial Results
October 29, 2026
Supernus Pharmaceuticals earnings: what to look for from SUPN
October 27, 2026
1 Russell 2000 Stock with Exciting Potential and 2 We Ignore
October 14, 2026
1 Healthcare Stock Worth Your Attention and 2 We Turn Down
October 09, 2026
1 Unprofitable Stock with Impressive Fundamentals and 2 We Avoid
September 30, 2026
2 Growth Stocks to Add to Your Roster and 1 We Question
September 28, 2026
3 Reasons SUPN is Risky and 1 Stock to Buy Instead
September 21, 2026
3 Cash-Heavy Stocks Walking a Fine Line
September 16, 2026
Supernus Pharmaceuticals to Participate in September Investor Conferences
September 02, 2026
3 Out-of-Favor Stocks We’re Skeptical Of
September 02, 2026
3 Small-Cap Stocks with Open Questions
August 25, 2026
1 Healthcare Stock with Exciting Potential and 2 We Ignore
August 18, 2026
Frequently Asked Questions
Is Supernus Pharmaceuticals, Inc. - Common Stock publicly traded?
Yes, Supernus Pharmaceuticals, Inc. - Common Stock is publicly traded.
What exchange does Supernus Pharmaceuticals, Inc. - Common Stock trade on?
Supernus Pharmaceuticals, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Supernus Pharmaceuticals, Inc. - Common Stock?
The ticker symbol for Supernus Pharmaceuticals, Inc. - Common Stock is SUPN on the Nasdaq Stock Market
What is the current price of Supernus Pharmaceuticals, Inc. - Common Stock?
The current price of Supernus Pharmaceuticals, Inc. - Common Stock is 41.92
When was Supernus Pharmaceuticals, Inc. - Common Stock last traded?
The last trade of Supernus Pharmaceuticals, Inc. - Common Stock was at 10/30/26 04:00 PM ET
What is the market capitalization of Supernus Pharmaceuticals, Inc. - Common Stock?
The market capitalization of Supernus Pharmaceuticals, Inc. - Common Stock is 2.23B
How many shares of Supernus Pharmaceuticals, Inc. - Common Stock are outstanding?
Supernus Pharmaceuticals, Inc. - Common Stock has 2B shares outstanding.